Ocular Therapeutix
Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
OCUL Key Statistics
Stock Snapshot
With a market cap of 2.03B, Ocular Therapeutix(OCUL) trades at $9.27. The stock has a price-to-earnings ratio of -6.63.
During the trading session on 2026-05-11, Ocular Therapeutix(OCUL) shares reached a daily high of $9.85 and a low of $9.19. At a current price of $9.27, the stock is +0.9% higher than the low and still -5.9% under the high.
Trading activity shows a volume of 2.54M, compared to an average daily volume of 2.71M.
The stock's 52-week range extends from a low of $6.23 to a high of $16.44.
The stock's 52-week range extends from a low of $6.23 to a high of $16.44.
OCUL News
Analyst Serge Belanger from Needham maintained a Buy rating on Ocular Therapeutix and keeping the price target at $18.00. Unlock hedge fund-level data and powe...
Reports Q1 revenue $10.79M, consensus $12.7M. “2026 is off to a tremendous start for Ocular, driven by the superiority demonstrated with AXPAXLI in the landmark...
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.